Freeline Company
Freeline is a clinical biotechnology company that develops transformative adeno-associated virus-vector-mediated systemic gene therapies. They use a designed AAV vector and capsid along with novel promoters and transgenes to deliver a functional copy of a therapeutic gene into human liver cells to express a functional level of the missing or dysfunctional protein into the patientвАЩs bloodstream. Their development programs including clinical trials focus on developing products.
Headquarters:
Stevenage, Herefordshire, United Kingdom
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Technology:
Others
Founded Date:
2015
Industry:
Gene Therapy